Sterlington Advises Humata Health Founder and CEO on Acquisition by R1
Sterlington Advises Humata Health Founder and CEO on Acquisition by R1
Sterlington is advising Jeremy Friese, MD, Founder and Chief Executive Officer of Humata Health (Humata) in connection with the company’s acquisition by R1 RCM Inc., a leader in healthcare revenue management.
Sterlington is advising the CEO on all aspects of the transaction. Humata is a leading health tech company providing AI-powered, touchless prior authorization solutions for health systems, payers, and patients. Its mission is to make prior authorization easy and seamless for providers, payers, and patients.
The Sterlington team was led by Executive Compensation partner Jeremy Goldstein, Corporate partner Christopher Harrison, Executive Compensation partner Audry Casusol, and Corporate partner Michael Gilligan.
This transaction marks Sterlington's latest healthcare-sector engagement, following Designs for Health, Florida Cancer Specialists & Research Institute, and Avanos Medical.
About Sterlington
Sterlington PLLC is a full-service law firm focusing on complex corporate, litigation, executive compensation, and private wealth matters. As a firm, we focus on the economic as well as the legal aspects of our matters.
Among other strengths, Sterlington is the ultimate law firm for founders, senior executives, and UHNWIs as well as their related businesses.
Visit us at www.sterlingtonlaw.com.
Amanda Sims
Communications Manager
Sterlington
amanda.sims@sterlingtonlaw.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260819578582/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The 10 Best Companies to Invest in Now
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
4 Stocks to Buy Before They Rise Further
The Top Funds for a Simpler Retirement Portfolio
United States